Finance

Beta
Lists
NU:NYSE
Nu Holdings Ltd.
$12.37
-0.72%
(-0.090) 1D
Jun 25, 1:42:41 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NU...
Open
$12.48
High
$12.64
Low
$12.23
Mkt. cap
60.14B
Avg. vol.
64.69M
Volume
18.86M
P/E ratio
19.08
52-wk high
$18.98
52-wk low
$11.20
EPS
$0.65
Beta
0.95
Shares outstanding
3.84B
No. of employees
10K
Open
$12.48
High
$12.64
Low
$12.23
Mkt. cap
60.14B
Avg. vol.
64.69M
Volume
18.86M
P/E ratio
19.08
52-wk high
$18.98
52-wk low
$11.20
EPS
$0.65
Beta
0.95
Shares outstanding
3.84B
No. of employees
10K
News stories
From sources across the web
About Nu Holdings Ltd.
CEODavid Vélez
Employees10K
Founded2013
HeadquartersSão Paulo, State of São Paulo, Brazil
SectorBank
Websitenubank.com.br
Analyst Ratings
Based on 7 analysts giving stock ratings to NU in the past 3 months
Buy
Buy
3
Hold
3
Sell
1
12 month forecast
Based on 7 Wall Street analysts offering 12 month price targets for NU in the last 3 months.
Highest
Current $12.37
$22.00 (+77.85%)
Average
$15.99 (+29.26%)
Lowest
$10.00 (-19.16%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Jorge Kuri
Morgan Stanley
Buy
Maintained
$21.00
+69.8%
06/18/2026
Darrin Peller
Wolfe Research
Buy
Maintained
$16.00
+29.3%
06/14/2026
Gustavo Schroden
Citi
Hold
Downgraded
$13.00
+5.1%
06/12/2026
Tito Labarta
Goldman Sachs
Hold
Maintained
$22.00
+77.8%
06/10/2026
James Friedman
Susquehanna
Hold
Downgraded
$13.00
+5.1%
06/03/2026
Unknown Analyst
Scotiabank
Hold
Downgraded
$13.00
+5.1%
06/03/2026
Mario Pierry
Bank of America Securities
Sell
Downgraded
$10.00
-19.2%
06/02/2026
Thiago Batista
UBS
Buy
Reiterated
$16.90
+36.6%
05/20/2026
Unknown Analyst
Jefferies
Buy
Maintained
$18.90
+52.8%
02/26/2026
Last report
May 14, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$0.19 / $0.21
-7.97%miss
Revenue / Est. (USD)
1.98B / 5.06B
-60.85%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.63B
1.92B
2.07B
1.98B
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
570.03M
594.44M
725.17M
759.81M
Operating expense
745.90M
802.06M
989.37M
1.03B
Total operating expenses
745.90M
802.06M
989.37M
1.03B
Operating income
880.39M
1.12B
1.08B
955.34M
Other non operating income
-
-
-
-
EBT including unusual items
879.36M
1.12B
1.08B
954.31M
EBT excluding unusual items
879.36M
1.12B
1.08B
954.31M
Income tax expense
242.38M
333.61M
182.90M
82.88M
Effective tax rate
27.56%
29.89%
16.97%
8.68%
Other operating expenses
175.87M
207.62M
264.21M
265.62M
Net income
636.84M
782.47M
892.38M
872.06M
Net profit margin
39.16%
40.76%
43.16%
44.03%
Earnings per share
0.14
0.17
0.19
0.19
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer